Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Christine Fernandes is active.

Publication


Featured researches published by Christine Fernandes.


Bioorganic & Medicinal Chemistry Letters | 2002

The synthesis and biological evaluation of a series of potent dual inhibitors of farnesyl and geranyl-Geranyl protein transferases.

Thomas J. Tucker; Marc T. Abrams; Carolyn A. Buser; Joseph P. Davide; Michelle Ellis-Hutchings; Christine Fernandes; Jackson B. Gibbs; Samuel L. Graham; George D. Hartman; Hans E. Huber; Dongming Liu; Robert B. Lobell; William C. Lumma; Ronald G. Robinson; John T. Sisko; Smith Am

We have prepared a series of potent, dual inhibitors of the prenyl transferases farnesyl protein transferase (FPTase) and geranyl-geranyl protein transferase I (GGPTase). The compounds were shown to possess potent activity against both enzymes in cell culture. Mechanistic analysis has shown that the compounds are CAAX competitive for FPTase inhibition but geranyl-geranyl pyrophosphate (GGPP) competitive for GGPTase inhibiton.


Bioorganic & Medicinal Chemistry Letters | 2002

Dual inhibitors of farnesyltransferase and geranylgeranyltransferase i

Diem N. Nguyen; Craig A. Stump; Eileen S. Walsh; Christine Fernandes; Joseph P. Davide; Michelle Ellis-Hutchings; Ronald G. Robinson; Theresa M. Williams; Robert B. Lobell; Hans E. Huber; Carolyn A. Buser

Compound 1 has been shown to be a dual prenylation inhibitor with FPTase (IC50=2 nM) and GGPTase-I (IC50=95 nM). Analogues of 1, which replaced the cyanophenyl group with various biaryls, led to the discovery of highly potent dual FPTase/GGPTase-I inhibitors. 4-trifluoromethylphenyl, trifluoropentynyl, and trifluoropentyl were identified as good p-cyano replacements.


Bioorganic & Medicinal Chemistry Letters | 2001

Evaluation of amino acid-based linkers in potent macrocyclic inhibitors of farnesyl-protein transferase

Douglas C. Beshore; Ian M. Bell; Christopher J. Dinsmore; Carl F. Homnick; J.Christopher Culberson; Ronald G. Robinson; Christine Fernandes; Eileen S. Walsh; Marc T. Abrams; Hema Bhimnathwala; Joseph P. Davide; Michelle Ellis-Hutchings; Hans A Huber; Kenneth S. Koblan; Carolyn A. Buser; Nancy E. Kohl; Robert B. Lobell; I-Wu Chen; Debra McLoughlin; Timothy V. Olah; Samuel L. Graham; George D. Hartman; Theresa M. Williams

A series of amino acid-based linkers was used to investigate the effects of various substituents upon the potency, pharmacokinetic properties, and conformation of macrocyclic farnesyl-protein transferase inhibitors (FTIs). As a result of the studies described herein, highly potent FTIs with improved pharmacokinetic profiles have been identified.


Journal of Medicinal Chemistry | 2002

3-Aminopyrrolidinone Farnesyltransferase Inhibitors: Design of Macrocyclic Compounds with Improved Pharmacokinetics and Excellent Cell Potency

Ian M. Bell; Steven N. Gallicchio; Marc T. Abrams; Lorena S. Beese; Douglas C. Beshore; Hema Bhimnathwala; Michael J. Bogusky; Carolyn A. Buser; J. Christopher Culberson; Joseph P. Davide; Michelle Ellis-Hutchings; Christine Fernandes; Jackson B. Gibbs; Samuel L. Graham; Kelly Hamilton; George D. Hartman; David C. Heimbrook; Carl F. Homnick; Hans E. Huber; Joel R. Huff; Kelem Kassahun; Kenneth S. Koblan; Nancy E. Kohl; Robert B. Lobell; Joseph J. Lynch; Ronald G. Robinson; A. David Rodrigues; Jeffrey S. Taylor; Eileen S. Walsh; and Theresa M. Williams


Bioorganic & Medicinal Chemistry Letters | 2006

Kinesin spindle protein (KSP) inhibitors. Part 2: the design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP.

Mark E. Fraley; Robert M. Garbaccio; Kenneth L. Arrington; William F. Hoffman; Edward S. Tasber; Paul J. Coleman; Carolyn A. Buser; Eileen S. Walsh; Kelly Hamilton; Christine Fernandes; Michael D. Schaber; Robert B. Lobell; Weikang Tao; Victoria J. South; Youwei Yan; Lawrence C. Kuo; Thomayant Prueksaritanont; Cathy Shu; Maricel Torrent; D C Heimbrook; Nancy E. Kohl; Hans E. Huber; George D. Hartman


Journal of Medicinal Chemistry | 2004

Potent N-(1,3-thiazol-2-yl)pyridin-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for the hERG ion channel.

Mark T. Bilodeau; Adrienne E. Balitza; Timothy J. Koester; Peter J. Manley; Leonard D. Rodman; Carolyn Buser-Doepner; Kathleen E. Coll; Christine Fernandes; Jackson B. Gibbs; David C. Heimbrook; William R. Huckle; Nancy E. Kohl; Joseph J. Lynch; Xianzhi Mao; Rosemary C. McFall; Debra McLoughlin; Cynthia Miller-Stein; Keith Rickert; Laura Sepp-Lorenzino; Jennifer M. Shipman; Raju Subramanian; Kenneth A. Thomas; Bradley K. Wong; Sean Yu; George D. Hartman


Journal of Medicinal Chemistry | 2003

Dual Protein Farnesyltransferase-Geranylgeranyltransferase-I Inhibitors as Potential Cancer Chemotherapeutic Agents.

S.J DeSolms; T.M Ciccarone; S.C MacTough; A.W Shaw; Carolyn A. Buser; Michelle Ellis-Hutchings; Christine Fernandes; Kelly Hamilton; Hans E. Huber; Nancy E. Kohl; Robert B. Lobell; Ronald G. Robinson; N.N Tsou; Eileen S. Walsh; Samuel Graham; Lorena S. Beese; Jeffrey S. Taylor


Bioorganic & Medicinal Chemistry Letters | 2004

Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG binding

Mark E. Fraley; Kenneth L. Arrington; Carolyn A. Buser; Patrice A. Ciecko; Kathleen E. Coll; Christine Fernandes; George D. Hartman; William F. Hoffman; Joseph J. Lynch; Rosemary C. McFall; Keith Rickert; Romi Singh; Sheri Smith; Kenneth A. Thomas; Bradley K. Wong


Journal of Medicinal Chemistry | 2001

Design and biological activity of (S)-4-(5-([1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl)imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potency.

Ian M. Bell; Steven N. Gallicchio; Marc Abrams; Douglas C. Beshore; Carolyn A. Buser; J. Christopher Culberson; Joseph P. Davide; Michelle Ellis-Hutchings; Christine Fernandes; Jackson B. Gibbs; Samuel Graham; George D. Hartman; David C. Heimbrook; Carl F. Homnick; Joel R. Huff; Kelem Kassahun; Kenneth S. Koblan; Nancy E. Kohl; Robert B. Lobell; Joseph J. Lynch; Patricia A. Miller; Charles Omer; A. David Rodrigues; and Eileen S. Walsh; Theresa M. Williams


Bioorganic & Medicinal Chemistry Letters | 2006

Kinesin spindle protein (KSP) inhibitors. Part 3: Synthesis and evaluation of phenolic 2,4-diaryl-2,5-dihydropyrroles with reduced hERG binding and employment of a phosphate prodrug strategy for aqueous solubility

Robert M. Garbaccio; Mark E. Fraley; Edward S. Tasber; Christy Olson; William F. Hoffman; Kenneth L. Arrington; Maricel Torrent; Carolyn A. Buser; Eileen S. Walsh; Kelly Hamilton; Michael D. Schaber; Christine Fernandes; Robert B. Lobell; Weikang Tao; Vicki J. South; Youwei Yan; Lawrence C. Kuo; Thomayant Prueksaritanont; Donald E. Slaughter; Cathy Shu; D C Heimbrook; Nancy E. Kohl; Hans E. Huber; George D. Hartman

Collaboration


Dive into the Christine Fernandes's collaboration.

Top Co-Authors

Avatar

Carolyn A. Buser

United States Military Academy

View shared research outputs
Top Co-Authors

Avatar

George D. Hartman

United States Military Academy

View shared research outputs
Top Co-Authors

Avatar

Robert B. Lobell

United States Military Academy

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eileen S. Walsh

United States Military Academy

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge